Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
17 November, 2018 06:05 IST
Lupin launches generic Tamiflu capsules in United States
Source: IRIS | 12 Feb, 2018, 03.22PM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Oseltamivir Phosphate Capsules, USP having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Oseltamivir Phosphate Capsules, USP , 30 mg (base), 45 mg (base), and 75 mg (base) are  the generic equivalent of Hoffman-La Roche, Inc.'s  Tamiflu Capsules, 30 mg, 45 mg, and 75 mg. Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) are indicated for the treatment of acute, uncomplicated influenza A and B in patients 2 weeks of age and older who have been symptomatic for no more than 48 hours, and prophylaxis of influenza A and B in patients 1 year and older.

Oseltamivir Phosphate Capsules, USP had annual sales of approximately USD 518 million in the US (IQVIA MAT December 2017).

Shares of the company gained Rs 18.8, or 2.29%, to trade at Rs 839.70. The total volume of shares traded was 110,577 at the BSE (3.11 p.m., Monday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Welspun Corp bags large order for supply of pipes for oil & gas project - 16-Nov-2018 15:36
Bharat Electronics pays Rs 644.1mn dividend to Govt of India - 16-Nov-2018 10:09
Shilpa Medicare gets tentative nod for Dimethyl Fumarate capsules - 16-Nov-2018 10:01
NIIT Tech partners with R3 to build solutions on Corda platform - 16-Nov-2018 09:42
Glenmark Pharma gets USFDA approval for Teriflunomide tablets - 16-Nov-2018 09:36
Steel Strips Wheels bags export order for EU caravan market - 15-Nov-2018 15:33
Lupin receives USFDA approval for Decitabine for injection - 15-Nov-2018 12:00
Zydus Cadila receives USFDA nod for Arsenic Trioxide injection - 15-Nov-2018 10:11
ICICI Bank raises retail term-deposit interest rates by upto 25bps - 15-Nov-2018 09:55
Lupin gets approval for Budesonide inhalation suspension - 13-Nov-2018 13:36
Suven Life Sciences secures 2 overseas product patents - 13-Nov-2018 10:18
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer